Endocrine & reproductive
One of 5 mechanistic pathways to 🧬 Organ-specific bioregulation · 7 options
Organ-specific peptides for the glands. Note how this maps onto the hormonal goals — the bioregulator argument is upstream of hormone replacement rather than an alternative to it.
This is the class where a before-and-after matters most, because the whole proposition is unverified. If a testicular bioregulator does what the programme claims, LH and testosterone are where it would show.
Total TestosteroneFree TestosteroneLH & FSHEstradiol, Sensitive (LC/MS-MS)Fasting InsulinHbA1c (Hemoglobin A1c)📋 Pre-TRT Baseline covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Testoluten
Testicular bioregulator, proposed to support endogenous Leydig-cell function. The theory would place it upstream of everything in the testosterone goal; there is no human trial to say whether it does anything.
💉 Testagen
A synthetic testicular tripeptide from the same programme.
💉 Ovagen
Ovarian and hepatic bioregulator, proposed in the programme to support follicular function. No independent human data exists for either target.
💉 Prostamax
Prostate bioregulator. Prostatilen, a related prostate peptide, has actual Russian clinical use in chronic prostatitis — the closest this class gets to established practice.
💉 Endoluten
Pineal-endocrine bioregulator, positioned in the programme as the master endocrine peptide.
💉 Suprefort
Pancreatic bioregulator, proposed for glucose regulation. If it works at all it belongs in the metabolic goal — which is exactly the sort of claim that needs a trial.
💉 Pancragen
The synthetic pancreatic tetrapeptide distilled from Suprefort's active fragment — the reductionist version of the same proposed signal.
The other 4 routes to organ-specific bioregulation
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
Organ-specific peptides for the glands. Note how this maps onto the hormonal goals — the bioregulator argument is upstream of hormone replacement rather than an alternative to it.
7 options are mapped to this pathway in the Vault, including Testoluten, Testagen, Ovagen, Prostamax. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 0 carry clinical validation and 7 are mechanistic predictions.
This is the class where a before-and-after matters most, because the whole proposition is unverified. If a testicular bioregulator does what the programme claims, LH and testosterone are where it would show. The markers worth checking are Total Testosterone, Free Testosterone, LH & FSH, Estradiol, Sensitive (LC/MS-MS).
Unproven is not the same as ineffective. Of the 7 options on this pathway, 0 have clinical validation and 7 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.